Histology | Survival/relapse data | Time interval to transplant | Additional considerations |
Diffuse large B cell lymphoma | Survival is equivalent to age- and sex-matched general population after EFS24 and PFS24 achieved | 2 years | |
Follicular lymphoma | No added mortality when compared with age- and sex-matched general population after EFS24 achieved | 2 years | |
Peripheral T cell lymphoma, NOS | 23% relapse within 5 years of EFS24, 78% 5-year survival after EFS24 achieved | 2 years | |
Burkitt lymphoma | 0.6% relapse after EFS24 achieved | 2 years | |
Hodgkin lymphoma | 10% relapse at 10 years after EFS24 achieved | 2 years | PET scan negative patients after initial treatment have a low rate of relapse |
Monoclonal B cell lymphocytosis | N/A | No wait time | |
Chronic lymphocytic leukemia | 83% 5-year survival untreated | 2 to 3 years after treatment | Consider if in remission with no CLL-IPI scores >4 |
Do you want to add Medilib to your home screen?